CBS News
137
2.67

Distribution and supply chain issues likely with COVID-19 vaccine.

Moderna Therapeutics is touting results from its first phase of testing for a coronavirus vaccine. But problems are likely to arise once a cure is developed. Politico's health care reporter Sarah Owermohle joins CBSN's Reena Ninan to explain how the Trump administration may have issues with distributing and developing a vaccine.

Watch video on channel "CBS News"

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies